US FDA clears Vivos Therapeutics' oral device for sleep apnea

 Vivos Therapeutics (VVOS.O) said on Wednesday the U.S. health regulator has cleared its oral device for severe obstructive sleep apnea (OSA), leading a massive rally in the company's shares before the bell.